Cell based assay market size was valued at US$ 15.2 Billion in 2020 and is projected to reach US$ 25.38 Billion at a CAGR of 7.6% by 2027 during the forecast period 2021- 2027. Cell-based Assay is the analytical technique to determine the different parameters such as biochemical or cellular functions of a living cell. Cell-based Assay is used in the research of new drugs by using functional cells as diagnostic tools. The cell based Assay is commonly used to measure motility, toxicity, cell proliferation, enzyme activity, and morphology in diagnostics and drug discovery. Cell based Assay is carried in several therapeutic areas such as cancer, stem cells, immunology, and others. In July 2016, Abenex acquired the Cisbio BioAssay from Argos Soditic for developing its product portfolio.Cell based assay market report gives a comprehensive outlook across the globe with special emphasis on key regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa (MEA). The report gives historical, current, and future market sizes (US$ Mn) on the basis of product type, application, end user and geographic regions. This report studies market dynamics elaborately to identify the current trends & drivers, future opportunities, and possible challenges to the key stakeholders operating in the market.